Lupin Ltd

US FDA woes continue to haunt Indian companies and Lupin Labs is no different. The stock has fallen to levels of Rs 1,303, which is very close to its 52-week low of Rs 1,303. However, at the current market price the stock maybe a good bet. In terms of valuations this stock is now quoting at a 1-year forward p/e of just 15 times, which makes it one of the cheapest pharma stocks. Recently, the company received an approval from the US FDA for selling its hypertension drug. If you are looking to buy the stock, it may not be a bad bet at the current levels. Buy, if you have a long term perspective in mind.

Sun Pharma

This is India's largest pharma company. The stock has fallen from levels of Rs 854 to the current levels of Rs 634.

The company has had a problem with the US FDA, which has had the potential to hit exports. There are worries some margin pressures at its subsidiary Taro. However, the research and development initiatives and the several products in the pipeline is a big initiative.

If US FDA worries are resolved, the stock has the potential to bounce back. A risky stock that has potential to generate returns.

Tech Mahindra

Tech Mahindra too is very close to its 52-week low of Rs 404. IT stocks like pharma stocks have been badly hit by H1B visa worries in the US and the sharp gains in the Indian rupee.

However, at the current market price, one gets a decent dividend yield of near 3 per cent from the stock of Tech Mahindra. It is not a bad share to take a risk. Most IT company stocks have fallen, though Infosys would be a better bet in terms of dividend yields.

Coal India

Coal India is another stock that has dropped and has now fallen to 52-week lows of Rs 274. Recently, there were reports of some of its mines being downgraded over quality issues, which has led to the stock falling.

However, at a time when the index is hitting lifetime highs, it would not be a bad idea to buy a stock at 52-week low price. In fact, the dividend yield at Coal India of around 6-7 per cent, makes the stock a good bet for tax free dividend. A good stock to buy keeping a long term perspective in mind.

Aurobindo Pharma

This is another pharma stock in India that has hit a 52-week low and joins the likes of Dr Reddys and Lupin Labs. The company recently received 6 warnings from the US FDA for its Hyderabad Unit.

Companies that receive its observations must respond in writing or the end result could be an import alert, which means they cannot export to the US. While this is another stock that has dropped, it may not be the most attractive in terms of valuations. You can have many other stocks from the pharma sector that you could choose from.

Infosys

Infosys is another blue chip stock worthy of investment. At a price of Rs 924, you get a decent dividend yield of 5 per cent. Not a bad bet for those looking at long-term investment.

Disclaimer

This article is strictly for informational purposes only. It is not a solicitation to buy, sell in securities or other financial instruments. Greynium Information Technologies Pvt Ltd, its subsidiaries, associates and the author of this article do not accept culpability for losses and/or damages arising based on information in this article.